Stephanie Han

Stephanie (Xiao) Han is a highly experienced professional in the field of cell biology and immunology, currently serving as a Senior Consultant at CytoHub, Inc. Previously, Stephanie held key roles including Senior Manager of iPSC Development at Resilience and Senior Scientist in Immunology at BlueRock Therapeutics. Earlier experience includes working as a Scientist in Discovery Biology at Semma Therapeutics, which was later acquired by Vertex. Stephanie's academic background includes a B.S. in Laboratory Medicine and a Ph.D. in Biochemistry and Molecular Biology, both obtained from Peking University.